Lack of authorization to carry out swabs for Covid-19 and omitted or delayed communication of positive cases emerged following clinical analyzes.
These are some of the irregularities found by the Nas that in the last week have checked almost 300 companies and analysis laboratories, private and affiliated, and other structures operating in the trade and in the provision of molecular, antigenic and serological analysis tests. centers.
94 criminal and administrative violations are contested, for a sum of 145 thousand euros in fines.